FRAMINGHAM – A Framingham biotech company laid off about one-third of its staff to start the month of August.
Berg LLC has about 100 employees, and laid off about 30 of them in a reorganization on August 1.
In 2015, the biotech company had 225 employees, with about 125 in Framingham and about 100 in Nashville, Tennessee at a manufacturing plant
In January 2018, BERG LLC spun off its manufacturing division into its own company – PMI BioPharma Solutions LLC.
The company is privately held.
Although the company is headquartered on Old Conn Path in Framingham it describes itself as a “Boston-based biopharma company focused on taking a bold back to biology approach to therapeutic discovery using its unique AI-based Interrogative Biology® platform.”
The company uses “patient biology and artificial intelligence-based analytics to engage the differences between healthy and disease environments. The patient’s own biology drives the platform’s results and guides us in the discovery and development of drugs, diagnostics and healthcare applications. Our platform utilizes patient population health data to bring actionable Patient IntelligenceTM to precision medicine applications. This means faster discovery and development of treatments, more effective precision treatments for individuals as well as a reduction in costs to our healthcare systems,” according to its website.
BERG, on its website said it “has a robust product portfolio in oncology, endocrinology and neurology with mature assets in oncology entering mid and late stage trials.”